CN101843787B - 一种治疗前列腺增生的中药 - Google Patents
一种治疗前列腺增生的中药 Download PDFInfo
- Publication number
- CN101843787B CN101843787B CN2009102358636A CN200910235863A CN101843787B CN 101843787 B CN101843787 B CN 101843787B CN 2009102358636 A CN2009102358636 A CN 2009102358636A CN 200910235863 A CN200910235863 A CN 200910235863A CN 101843787 B CN101843787 B CN 101843787B
- Authority
- CN
- China
- Prior art keywords
- chinese
- chinese medicament
- chinese medicine
- radix
- fine powder
- Prior art date
Links
- 239000003814 drugs Substances 0.000 title claims abstract description 27
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000000843 powders Substances 0.000 claims description 17
- 239000002775 capsules Substances 0.000 claims description 16
- 210000000582 Semen Anatomy 0.000 claims description 11
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 10
- 239000000203 mixtures Substances 0.000 claims description 4
- 238000000034 methods Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 229940023488 Pill Drugs 0.000 claims description 2
- 239000008187 granular materials Substances 0.000 claims description 2
- 239000006187 pills Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 14
- 210000004369 Blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 238000005728 strengthening Methods 0.000 abstract description 4
- 240000004678 Panax pseudoginseng Species 0.000 abstract description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 239000002994 raw materials Substances 0.000 abstract description 2
- 239000011901 water Substances 0.000 abstract description 2
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 230000003213 activating Effects 0.000 abstract 1
- 230000002522 swelling Effects 0.000 abstract 1
- 201000001923 urinary system diseases Diseases 0.000 abstract 1
- 230000027939 micturition Effects 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 230000025627 positive regulation of urine volume Effects 0.000 description 6
- 210000002700 Urine Anatomy 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 201000010099 diseases Diseases 0.000 description 4
- AXONCVPTTFHNOI-UHFFFAOYSA-N Kairine Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940079593 drugs Drugs 0.000 description 3
- 230000001737 promoting Effects 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000001939 inductive effects Effects 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 1
- 208000006750 Hematuria Diseases 0.000 description 1
- 210000000088 Lip Anatomy 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 239000010419 fine particles Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000002360 preparation methods Methods 0.000 description 1
- 230000002485 urinary Effects 0.000 description 1
Abstract
一种治疗前列腺增生的中药，属治疗泌尿系统疾病的中药领域；其目的是效果好，见效快；本发明采用车前子、当归、生地、泽泻、灵芝、三七等原料制成；它具有扶正培本，益气养血，活血化瘀，利水消肿，渗湿通淋的作用，具有效果显著，药效确切，见效较快的优点。
Description
一种治疗前列腺增生的中药
技术领域
[0001] 本发明属于治疗泌尿系统疾病的中药领域。 背景技术
[0002] 目前的用于治疗男性前列腺增生的中药方面，存在两个方面的不足：一是效果不 够明显，二是见效比较迟缓，以致于大批前列腺增生患者因长期得不到有效药物的治疗，经 常尿频、尿急、尿痛、尿不尽，迁延不愈，非常痛苦，并常并发膀胱炎、血尿等症状。患者及其 家属很不满意。
[0003] 针对以上提出的问题，本发明提供一种治疗前列腺增生的中药，它能解决以往此 类中药效果不够明显，见效比较迟缓的问题，效果好，见效快，具有效果显著，药效确切，见 效较快的优点。
发明内容
[0004] 本发明是通过以下技术方案来实现的：
[0005] 1、一种治疗前列腺增生的中药，采用中药原料制备，配方为（按重量比）：
[0006] 车前子4-30份当归4-30份 生地4_30份
[0007] 泽泻4-30份 灵芝2-15份 三七3_20份
[0008] 这种治疗前列腺增生的中药是由下列方法制成的：
[0009] (1)按上述重量比，将车前子、当归、生地、泽泻经常规水提取工艺提取，制成浸膏 细粉；
[0010] (2)按上述重量比，将灵芝、三七分别研成细粉，与浸膏细粉混合，搅拌均勻；根据 需要，可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。
[0011] 本发明是根据民间传统配方，根据中医扶正培本、活血化瘀的理论，精心研制而 成。方中灵芝、生地益气养血，扶正培本；当归、三七活血化瘀止痛；辅以泽泻利小便，清湿 热，利水消肿；合用车前子清热利尿，渗湿通淋。诸药配伍，相得益彰，具有扶正培本，益气养 血，活血化瘀，利水消肿，渗湿通淋之功，效果好，见效快，具有效果显著，药效确切，见效较 快的优点。
具体实施方式
[0012] 通过以下实施方式对本发明做具体说明：
[0013] 1、取以下配方（重量按克为单位）：
[0014] 车前子80克 当归80克 生地80克
[0015] 泽泻80克 灵芝40克 三七60克
[0016] 按规定重量，用常规水提取工艺将车前子、当归、生地、泽泻提取，制成浸膏细粉90 克，将灵芝、三七分别研成细粉，与浸膏细粉混合，搅拌均勻，制成细小颗粒，装0号胶囊，制 成中药胶囊750粒，每粒胶囊内含中药细粉及提取物0.观克。
3[0017] 2、取以下配方（重量按克为单位):
[0018] 车前子160克 当归180克 生地180克
[0019] 泽泻160克 灵芝80克 三七100克
[0020] 按上述同样的方法，制成中药胶囊1657粒，每粒胶囊内含中药细粉及提取物0. 28克。
[0021] 3、取以下配方（重量按克为单位）：
[0022] 车前子300克当归300克 生地300克
[0023] 泽泻300克 灵芝150克 三七200克
[0024] 按上述同样的方法，制成中药胶囊2535粒，每粒胶囊内含中药细粉及提取物0. 28克。
[0025] 4、取以下配方（按重量比）：
[0026] 车前子6份 当归6份 生地6份
[0027] 泽泻6份 灵芝3份 三七4份
[0028] 按上述同样的方法，制成中药胶囊，每粒胶囊内含中药细粉及提取物0. 28克。
[0029] 5、取以下配方（按重量比）：
[0030] 车前子25份 当归20份 生地20份
[0031] 泽泻25份 灵芝12份 三七15份
[0032] 按上述同样的方法，制成中药胶囊，每粒胶囊内含中药细粉及提取物0. 28克。
[0033] 临床资料：
[0034] 本发明以前列腺增生为例，经7例临床观察。选择中医诊断前列腺增生为标准： 男性肢软乏力，身体虚弱，小便不畅——尿频、尿急、尿痛、尿不尽、尿潴留。如上症状，即可 确诊。在确诊观察的对象中，全部为男性，无其它严重疾病，年龄为47岁-82岁，平均年龄 66. 5 岁。
[0035] 疗效判定：
[0036] 1、显效：体质增强，身上有劲；尿频、尿急、尿痛明显缓解；尿潴留、尿不尽减轻。
[0037] 2、有效：体质增强，身上有劲；尿频、尿急、尿痛有所缓解。
[0038] 3、无效：病症无变化。
[0039] 临床实验时，停服其它药物和保健营养品。服用本发明中药胶囊，观察3个月，为 一个疗程。服用方法：每日2次，每次5粒胶囊，每粒胶囊内含中药细粉及提取物0.¾克， 饭后温开水送服，30天后症状即有缓解，服用3个月后，症状明显改善。临床实验的7人中， 显效3人，有效3人，无效1人，总有效率85. 7%。
Claims (1)
1. 一种治疗前列腺增生的中药，其特征是，它是以下列重量比的组分制成的： 车前子4-30份 当归4-30份 生地4-30份 泽泻4-30份 灵芝2-15份 三七3-20份 这种治疗前列腺增生的中药是由下列方法制成的：(1)按上述重量比，将车前子、当归、生地、泽泻经常规水提取工艺提取，制成浸膏细粉；(2)按上述重量比，将灵芝、三七分别研成细粉，与浸膏细粉混合，搅拌均勻；根据需 要，制成中药颗粒剂、散剂、胶囊剂、水丸剂、片剂剂型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102358636A CN101843787B (zh) | 2009-10-28 | 2009-10-28 | 一种治疗前列腺增生的中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102358636A CN101843787B (zh) | 2009-10-28 | 2009-10-28 | 一种治疗前列腺增生的中药 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843787A CN101843787A (zh) | 2010-09-29 |
| CN101843787B true CN101843787B (zh) | 2011-06-29 |
Family
ID=42768725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102358636A CN101843787B (zh) | 2009-10-28 | 2009-10-28 | 一种治疗前列腺增生的中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843787B (zh) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102068594A (zh) * | 2010-09-16 | 2011-05-25 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN101972345A (zh) * | 2010-10-14 | 2011-02-16 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN101972426A (zh) * | 2010-10-21 | 2011-02-16 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN101961407A (zh) * | 2010-10-27 | 2011-02-02 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN101966257A (zh) * | 2010-11-04 | 2011-02-09 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN101979004A (zh) * | 2010-11-04 | 2011-02-23 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN101991700A (zh) * | 2010-11-11 | 2011-03-30 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN102139009A (zh) * | 2010-11-18 | 2011-08-03 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN102091225A (zh) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN102114100A (zh) * | 2010-12-13 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN102114122A (zh) * | 2010-12-13 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN102172377A (zh) * | 2010-12-20 | 2011-09-07 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN102172374A (zh) * | 2010-12-20 | 2011-09-07 | 北京绿源求证科技发展有限责任公司 | 一种治疗前列腺增生的中药 |
| CN102114138A (zh) * | 2010-12-24 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | 一种治疗慢性前列腺炎的中药 |
| CN103301266B (zh) * | 2013-05-11 | 2015-04-15 | 山西医科大学第二医院 | 一种治疗前列腺肥大的中药 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686529A (zh) * | 2005-05-20 | 2005-10-26 | 李素梅 | 一种治疗糖尿病的中成药 |
| CN1947777A (zh) * | 2006-06-18 | 2007-04-18 | 芮育健 | 茯苓枸杞子元参生津止渴治疗糖尿病的新方法 |
| CN101081280A (zh) * | 2006-05-31 | 2007-12-05 | 刘风斌 | 消渴降糖胶囊 |
-
2009
- 2009-10-28 CN CN2009102358636A patent/CN101843787B/zh not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1686529A (zh) * | 2005-05-20 | 2005-10-26 | 李素梅 | 一种治疗糖尿病的中成药 |
| CN101081280A (zh) * | 2006-05-31 | 2007-12-05 | 刘风斌 | 消渴降糖胶囊 |
| CN1947777A (zh) * | 2006-06-18 | 2007-04-18 | 芮育健 | 茯苓枸杞子元参生津止渴治疗糖尿病的新方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843787A (zh) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102772745B (zh) | 一种治疗癌症的中药制剂及其制备方法 | |
| CN101843773B (zh) | 一种治疗肝硬化的中药 | |
| CN101843699B (zh) | 一种治疗前列腺增生的中药 | |
| CN101843787B (zh) | 一种治疗前列腺增生的中药 | |
| CN101972386A (zh) | 一种治疗糖尿病痛风的中药 | |
| CN101537146B (zh) | 一种治疗结肠癌的中药 | |
| CN101843694B (zh) | 一种治疗慢性肝炎的中药 | |
| CN102091188A (zh) | 一种治疗糖尿病性肾病的中药 | |
| CN102389473A (zh) | 一种治疗糖尿病性便秘的中药 | |
| CN102138969A (zh) | 一种治疗糖尿病性腹泻的中药 | |
| CN102114074A (zh) | 一种治疗糖尿病性腹泻的中药 | |
| CN101530515B (zh) | 一种治疗糖尿病并发前列腺肿大的中药 | |
| CN102139049A (zh) | 一种治疗糖尿病性皮肤瘙痒的中药 | |
| CN102048831A (zh) | 一种治疗肝硬化的中药 | |
| CN101940674A (zh) | 一种治疗糖尿病周围神经病变的中药 | |
| CN102091225A (zh) | 一种治疗慢性前列腺炎的中药 | |
| CN102172374A (zh) | 一种治疗前列腺增生的中药 | |
| CN102068594A (zh) | 一种治疗慢性前列腺炎的中药 | |
| CN102114172A (zh) | 一种治疗前列腺增生的中药 | |
| CN101530508B (zh) | 一种治疗卵巢癌的中药 | |
| CN102327411A (zh) | 一种治疗糖尿病性胃麻痹的中药 | |
| CN101406594B (zh) | 一种治疗肺部肿瘤的中药 | |
| CN101953924A (zh) | 一种治疗慢性肝炎的中药 | |
| CN101972422A (zh) | 一种治疗糖尿病性皮肤瘙痒的中药 | |
| CN101953955A (zh) | 一种治疗糖尿病周围神经病变的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| GR01 | Patent grant | ||
| C14 | Grant of patent or utility model | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130701 |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130701 Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166. Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20151028 |
|
| EXPY | Termination of patent right or utility model |